"Lymphomatoid Papulosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clinically benign, histologically malignant, recurrent cutaneous T-cell lymphoproliferative disorder characterized by an infiltration of large atypical cells surrounded by inflammatory cells. The atypical cells resemble REED-STERNBERG CELLS of HODGKIN DISEASE or the malignant cells of CUTANEOUS T-CELL LYMPHOMA. In some cases, lymphomatoid papulosis progresses to lymphomatous conditions including MYCOSIS FUNGOIDES; HODGKIN DISEASE; CUTANEOUS T-CELL LYMPHOMA; or ANAPLASTIC LARGE-CELL LYMPHOMA.
| Descriptor ID |
D017731
|
| MeSH Number(s) |
C04.557.386.480.750.800.528 C15.604.515.569.480.750.800.528 C20.683.515.761.480.750.800.528
|
| Concept/Terms |
Lymphomatoid Papulosis- Lymphomatoid Papulosis
- Lymphomatoid Papuloses
- Papuloses, Lymphomatoid
- Papulosis, Lymphomatoid
|
Below are MeSH descriptors whose meaning is more general than "Lymphomatoid Papulosis".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, T-Cell, Cutaneous [C04.557.386.480.750.800]
- Lymphomatoid Papulosis [C04.557.386.480.750.800.528]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, T-Cell [C15.604.515.569.480.750]
- Lymphoma, T-Cell, Cutaneous [C15.604.515.569.480.750.800]
- Lymphomatoid Papulosis [C15.604.515.569.480.750.800.528]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, T-Cell, Cutaneous [C20.683.515.761.480.750.800]
- Lymphomatoid Papulosis [C20.683.515.761.480.750.800.528]
Below are MeSH descriptors whose meaning is more specific than "Lymphomatoid Papulosis".
This graph shows the total number of publications written about "Lymphomatoid Papulosis" by people in this website by year, and whether "Lymphomatoid Papulosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphomatoid Papulosis" by people in Profiles.
-
Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review. J Cutan Pathol. 2023 Aug; 50(8):711-716.
-
Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA). Best Pract Res Clin Haematol. 2023 03; 36(1):101448.
-
Childhood lymphomatoid papulosis Type D, a rare and challenging diagnosis. Pediatr Dermatol. 2022 Nov; 39(6):943-945.
-
Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? Virchows Arch. 2021 Aug; 479(2):377-383.
-
Lymphomatoid Papulosis With a Unique T Follicular Helper-Like Phenotype. Am J Dermatopathol. 2020 Oct; 42(10):776-779.
-
Diagnosis of T-cell lymphoid proliferations of the skin: putting all the pieces together. Mod Pathol. 2020 01; 33(Suppl 1):83-95.
-
Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results. JAMA Dermatol. 2017 12 01; 153(12):1302-1306.
-
Primary cutaneous CD30(+) lymphoproliferative disorders. J Dtsch Dermatol Ges. 2016 Aug; 14(8):767-82.
-
Lymphomatoid Papulosis in Children and Adolescents: A Systematic Review. Am J Clin Dermatol. 2016 Aug; 17(4):319-27.
-
Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients. J Am Acad Dermatol. 2016 Jan; 74(1):59-67.